ライフサイエンスコーパス: in-hospital

1 concerns about patient care for older people in hospital.

2 intervention group did not complete the VHS in hospital.

3 , and recorded the nutritional therapy given in hospital.

4 420 000 cases annually, of whom 230 000 die in hospital.

5 postoperative complications and 31 (4%) died in-hospital.

6 plications for safety improvement strategies in hospitals.

7 healthcare team are associated with PICC use in hospitals.

8 mportant antibiotic stewardship intervention in hospitals.

9 4) were single births; and 5) were delivered in hospitals.

10 program, designed to improve pain management in hospitals.

11 .001) and a reduced rate of mortality at the in-hospital (1.5% versus 2.4%, P<0.001) and 30-day (2.3%

12 but significantly correlated with reductions in hospital 30-day mortality rates after discharge.

13 , monthly aggregate changes across hospitals in hospital 30-day RAMRs after discharge varied by condi

14 cardial infarction, or pneumonia, reductions in hospital 30-day readmission rates were weakly but sig

15 e one of the most common bacterial pathogens in hospital-acquired infections in the United States.

16 However, OmpA clinical implication in hospital-acquired infections remains unknown.

17 ms associated with genetic susceptibility to in-hospital acute kidney injury.

18 RNIs) have been associated with improvements in hospital admissions and mortality from heart failure

19 We saw no difference in hospital admissions between groups (12.5% in the co-t

20 ly successful CA for AF female sex, AF type, in-hospital AF relapse and comorbidities such as renal f

21 planned hospital death (probability of dying in hospital after unplanned admission).

22 The primary outcome was incidence of in-hospital AKI according to AKI network criteria.

23 hods, we determined the relationship between in-hospital AKI and risk of post-discharge adverse event

24 Compared with no AKI, in-hospital AKI was associated with higher post-discharg

25 In hospitals allocated to the control group, usual care

26 The correlation in hospital AMI achievement scores for each age group wa

27 r to confidently confirm or refute outbreaks in hospital and community settings.

28 n agriculture, and prophylactic applications in hospital and community settings.

29 as fundamental to achieving high performance in hospital and other healthcare settings, the ability t

30 Assessing cognitive status both in hospital and post-discharge is important for detectin

31 potential point-of-care diagnostic platform in hospitals and for use by regulatory agencies for bett

32 -Global were randomised, phase 3 trials done in hospitals and specialist liver centres in 14 countrie

33 Secondary outcomes were in-hospital and 1-year mortality.

34 HF risk scores were similarly predictive of in-hospital and 30-, 90-, and 180-day postdischarge mort

35 condary outcomes including 30-day mortality, in-hospital and 30-day death/stroke, procedural success,

36 show goodness-of-fit test) for prediction of in-hospital and 30-day mortality and compared its predic

37 In-hospital and 30-day mortality rates were 4.4% and 5.4

38 0.67; 95% confidence interval, 0.62-0.72 for in-hospital and 30-day mortality, respectively) and good

39 the designation of outlier hospitals between in-hospital and 30-day RSMRs was 78%, but chance-correct

40 al/ethnic disparities have been described in in-hospital and 30-day settings.

41 s, revascularization, use of medication, and in-hospital and long-term cardiovascular events.

42 troponin elevation and its association with in-hospital and long-term outcomes among patients with d

43 ncreased MDSC appearance was associated with in-hospital and long-term outcomes.

44 decompensated HFpEF is associated with worse in-hospital and postdischarge outcomes, independent of o

45 n 7 days; barotrauma within 7 days; and ICU, in-hospital, and 6-month mortality.

46 continuum of care, including their pre-AMI, in-hospital, and post-AMI periods, and highlight gaps in

47 re risk to residents than believed, implying in-hospital antibiotic use must be better controlled and

48 To assess the variation in hospitals' approaches to intraoperative fluid managem

49 ases caused by antibiotic-resistant bacteria in hospitals are the outcome of complex relationships be

50 Maternal outcomes included in-hospital arrhythmias, eclampsia or preeclampsia, cong

51 ventilation decreased in hospital C but not in hospital B.

52 th more efficacious than usual care, whereas in-hospital behavioral interventions were not (RR: 1.05;

53 date, bivalirudin was associated with lower in-hospital bleeding and mortality given current practic

54 Outcomes were in-hospital bleeding and mortality.

55 Duration of mechanical ventilation decreased in hospital C but not in hospital B.

56 n and epinephrine treatment in patients with in-hospital cardiac arrest (IHCA).

57 h a higher proportion of black patients with in-hospital cardiac arrest achieved larger survival gain

58 rum concentrations 3 days after nontraumatic in-hospital cardiac arrest and out-of-hospital cardiac a

59 e found marked differences in survival after in-hospital cardiac arrest by race.

60 al cohort study of adult patients who had an in-hospital cardiac arrest from January 2000 through Dec

61 tion in racial differences in survival after in-hospital cardiac arrest has occurred that has been la

62 whether racial differences in survival after in-hospital cardiac arrest have narrowed over time and i

63 ine whether tracheal intubation during adult in-hospital cardiac arrest is associated with survival t

64 for out-of-hospital cardiac arrest than for in-hospital cardiac arrest patients.

65 er 31, 2014, a total of 112139 patients with in-hospital cardiac arrest who were hospitalized in inte

66 Among 112139 patients with in-hospital cardiac arrest, 30241 (27.0%) were black (me

67 Tracheal intubation is common during adult in-hospital cardiac arrest, but little is known about th

68 Among comatose children who survived in-hospital cardiac arrest, therapeutic hypothermia, as

69 hysiological decline in an effort to prevent in-hospital cardiac arrest.

70 registry, a US-based multicenter registry of in-hospital cardiac arrest.

71 support early tracheal intubation for adult in-hospital cardiac arrest.

72 rature interventions in children who had had in-hospital cardiac arrest.

73 Survival trends after in-hospital cardiopulmonary resuscitation (ICPR) for car

74 Registry (NCDR) CathPCI Registry to identify in-hospital care for PCI in the United States.

75 Median in-hospital CCI was comparable for both groups (DCD 38.2

76 In-hospital clinical complications including Q-wave myoc

77 No differences in hospital complications were noted between groups.

78 on, patient demographics, comorbidities, and in-hospital complications, but not by the mode of revasc

79 Costs to taxpayers were nearly $500000 in hospital costs alone.

80 2 months in models incorporating baseline or in-hospital covariates (P > 0.2).

81 for baseline covariates and subsequently for in-hospital covariates.

82 ata with number of hospital readmissions and in-hospital days over the next 12 months; the parameters

83 oalbuminemia was an independent predictor of in-hospital death (OR = 1.89, P = 0.014), even after adj

84 95% CI, 1.54-1.82) and had a higher risk of in-hospital death (RR, 1.18; 95% CI, 1.03-1.33) but had

85 001) were the most significant predictors of in-hospital death after adjusting for age.

86 The risk of in-hospital death also did not differ between patients e

87 s associated with a reduction in the odds of in-hospital death among patients aged 18-49 years (adjus

88 Outcomes were in-hospital death and the development of ischemic and he

89 ys was not associated with increased risk of in-hospital death compared with exclusive exposure to th

90 We studied 358 children with RSV-related in-hospital death from 23 countries across the world, wi

91 ctive was to determine the effect on risk of in-hospital death of time-dependent exposure to RBCs sto

92 The risk-adjusted rate of in-hospital death or withdrawal from treatment was not s

93 cific CriSTAL criteria and the prediction of in-hospital death was a secondary objective.

94 The strongest predictors of in-hospital death were cardiogenic shock (odds ratio, 6.

95 d with a significant reduction in mortality (in-hospital death, 4.4%-2.3%; P=0.001) that was not appa

96 ondary outcomes included ICU admission rate, in-hospital death, functional status, and quality of lif

97 net reclassification improvement (0.346 for in-hospital death, P = 0.004; 0.306 for 1-year death, p

98 pital admissions, and 59 600 (48 000-74 500) in-hospital deaths in children younger than 5 years.

99 Three (5%) in-hospital deaths occurred.

100 In-hospital deaths were significantly higher in the hypo

101 In-hospital delay of acute appendectomy in children was

102 404 patients were randomized; 390 completed in-hospital delirium assessments (median [interquartile

103 is predicted by baseline education level and in-hospital delirium.

104 dividuals >18 years of age with a first-time in-hospital diagnosis of heart failure.

105 vations and the themes of basic nursing care in hospital environment were identified.

106 national Classification of Diseases-10 codes in Hospital Episode Statistics data, linked to the Offic

107 t, was significantly associated with adverse in-hospital events in real-world patients, regardless of

108 istrative secondary diagnosis codes to study in-hospital events); and (3) data analysis (accounting f

109 blood unit patients had received on each day in hospital: exclusively exposed to RBCs stored no longe

110 , first documented rhythm, location of event in hospital, extracorporeal CPR, and hypotension as the

111 eated to track hospital outcomes (78.9% with in-hospital follow-up).

112 ciated with increased odds of patients dying in hospital following common surgical procedures.

113 Midwifery Council, and patients who had been in hospital for more than 24h and who could consent to p

114 ized controlled trial to study the impact of in-hospital guidance for acute decompensated HF treatmen

115 Pediatric CDI in hospitals has remained stable over the last 6 years a

116 ided in a safe and practical manner to allow in-hospital human therapeutic trials.

117 ted to general medicine and surgery services in hospital in the non-intensive-care setting.

118 Antibiotic resistance (AR) in hospitals in countries such as India is potentially p

119 Of 78,807 patients, 8382 (10.6%) died in hospital including 6516 (78%) after severe traumatic

120 fection declines were driven by improvements in hospital infection control, then transmitted (seconda

121 significant absolute and relative decreases in hospital length of stay and postoperative complicatio

122 e of antibiotics, and leading to a reduction in hospital length of stay.

123 In-hospital major adverse cardiac and cerebral events oc

124 The rates of in-hospital major adverse cardiovascular events were sig

125 Study outcomes included in-hospital major adverse cardiovascular events, 30-day

126 he treatment SVG disease have lower rates of in-hospital major adverse cardiovascular events, 30-day

127 es assessed included adjusted and unadjusted in-hospital major adverse events.

128 % CI, 0.71-1.15; P=0.41), but lower rates of in-hospital major bleeding (OR, 0.62; 95% CI, 0.40-0.98;

129 ing resistance profiles of bacterial strains in hospital microbiology and public health settings.

130 cardiographic (ECG) monitoring is ubiquitous in hospitals, monitoring practices are inconsistent.

131 1]; P=0.001), and there was no difference in in-hospital morbidity.

132 d States was not associated with a reduction in hospital mortality beyond existing preimplementation

133 ts undergoing elective BAV or TAVR, rates of in-hospital mortality (2.9% versus 3.5%; P=0.60), clinic

134 In-hospital mortality (45 [2.0] vs 37 [1.6]; P = .23) an

135 71], and 0.88 [0.84-0.92], respectively) and in-hospital mortality (adjusted odds ratio [95% CI], 0.7

136 olR was associated with increased hazard for in-hospital mortality (aHR 3.48; 95% confidence interval

137 ciate with the composite end point of AKI or in-hospital mortality (AKI/death).

138 minutes from "time-zero." Main outcomes were in-hospital mortality (all cohorts) and total direct cos

139 ted significantly greater discrimination for in-hospital mortality (crude AUROC, 0.753 [99% CI, 0.750

140 itial antimicrobial was also associated with in-hospital mortality (odds ratio = 1.05; 95% CI, 1.03-1

141 4 vs quartile 1, 1.05; 95% CI, 0.65-1.68) or in-hospital mortality (odds ratio quartile 4 vs quartile

142 dle was associated with higher risk-adjusted in-hospital mortality (odds ratio, 1.04 per hour; 95% co

143 ral corticosteroids were not associated with in-hospital mortality (odds ratio, 1.41; 95% CI, 0.87-2.

144 ents had significantly greater risk-adjusted in-hospital mortality (odds ratio, 1.89 [95% CI, 1.79-2.

145 afebrile remained a significant predictor of in-hospital mortality (odds ratio, 4.3; 95% CI, 2.2-8.2;

146 s (OR, 31.8; 95% CI, 4.3-236.3) and maternal in-hospital mortality (OR, 79.1; 95% CI, 23.9-261.8).

147 noninvasive ventilation failure (p = 0.87), in-hospital mortality (p = 0.88), 30-day readmission for

148 f noncardiac procedure use and risk-adjusted in-hospital mortality (P<0.001 for all).

149 after TBI was associated with a reduction of in-hospital mortality (pooled OR 0.39, 95% CI: 0.27-0.56

150 ment delays in antibiotic administration and in-hospital mortality among patient encounters with comm

151 Risk-adjusted in-hospital mortality among the renal transplant group w

152 s case volume for the receiving hospital and in-hospital mortality among transferred patients with se

153 ity, the agreement between risk-standardized in-hospital mortality and 30-day mortality was modest.

154 hysicians' and nurses' binary predictions of in-hospital mortality and 6-month outcomes, including mo

155 e complicated type B AD, stroke, paraplegia, in-hospital mortality and follow-up mortality appeared l

156 s (odds ratio = 1.47; 95% CI = 1.30-1.66) of in-hospital mortality and lower odds (odds ratio = 0.8;

157 The primary outcome was in-hospital mortality and the secondary outcome was medi

158 The primary outcome was in-hospital mortality and the secondary outcomes include

159 We aimed to assess the risk of in-hospital mortality associated with transfusing blood

160 ment, there was no significant difference in in-hospital mortality between centers with and without o

161 ignificant differences in the risk-adjusted, in-hospital mortality between the 2 groups in prespecifi

162 Risk-adjusted in-hospital mortality declined slightly in the overall c

163 Observed in-hospital mortality decreased from 5.7% to 2.9%, and 1

164 In-hospital mortality differences between females and ma

165 In-hospital mortality for females declined from 61.0% in

166 f a CDSS reduces hospital length of stay and in-hospital mortality for patients with AKI.

167 ntibiotic administration are associated with in-hospital mortality in community-acquired sepsis.

168 ck are the independent predictors of 50 days in-hospital mortality in culture negative neutrocytic as

169 tes of percutaneous coronary intervention or in-hospital mortality in New York.

170 We observed higher rates of in-hospital mortality in patients who developed moderate

171 CriSTAL score, palliative care referral, and in-hospital mortality in patients who received RRT servi

172 of the INFORM trial was to assess all-cause in-hospital mortality in patients with blood group A and

173 he primary aim of this study was to describe in-hospital mortality in subarachnoid hemorrhage patient

174 2,683 had community-acquired sepsis, with an in-hospital mortality of 11%.

175 However, when using the combined outcome of in-hospital mortality or discharge to hospice (risk-stan

176 However, the combined outcome of in-hospital mortality or discharge to hospice showed muc

177 In-hospital mortality or ICU length of stay (LOS) of 3 d

178 The all-cause 30-day in-hospital mortality rate was 10 in 10 000.

179 The in-hospital mortality rate was 20.4%.

180 The overall 3-day, in-ICU, and in-hospital mortality rates were 14.1%, 37.3%, and 41.3%

181 ; P < .001 for trend), whereas risk-adjusted in-hospital mortality remained unchanged during the stud

182 or more had greater prognostic accuracy for in-hospital mortality than SIRS criteria or the qSOFA sc

183 In-hospital mortality using clinical criteria declined (

184 In-hospital mortality was 1%, and CCI was 21 +/- 19.

185 Unadjusted in-hospital mortality was 1.86% for low-volume operators

186 Overall in-hospital mortality was 17.8% (55 patients): 227 patie

187 Overall, in-hospital mortality was 2.7%.

188 In-hospital mortality was 3% (5/147).

189 In-hospital mortality was 33.2%, with median length of s

190 e ventilation failure occurred in 15.2%, and in-hospital mortality was 6.5%.

191 In-hospital mortality was 8.8% and did not vary across t

192 In-hospital mortality was higher among patients receivin

193 Discrimination for in-hospital mortality was highest for NEWS (area under t

194 In-hospital mortality was significantly higher for those

195 Thirty-day in-hospital mortality was the primary outcome.

196 Procedural and in-hospital mortality were 1.4% and 8.5%, respectively.

197 In-hospital mortality, 30-day mortality, and 1-year mort

198 In-hospital mortality, 30-day mortality, and length of s

199 improved outcomes, including lower rates of in-hospital mortality, 30-day readmission, 30-day mortal

200 ficiary-years of fee-for-service enrollment, in-hospital mortality, 30-day stroke or death, 30-day st

201 ed with ventricular arrhythmias and maternal in-hospital mortality, although these outcomes were rare

202 estimated incidence during the study period, in-hospital mortality, and 1-year mortality.

203 had similar rates of unplanned readmissions, in-hospital mortality, and acute myocardial infarction d

204 systemic hemorrhage, any rt-PA complication, in-hospital mortality, and modified Rankin Scale at disc

205 on-to-treat basis for the primary outcome of in-hospital mortality, and secondary outcomes including

206 Patients with CKD or ESRD had greater in-hospital mortality, hospital length of stay, hemorrha

207 outcome measures included serious morbidity, in-hospital mortality, intensive care unit admissions, a

208 e evaluated rates of hospitalization for AF, in-hospital mortality, length of stay, and hospital paym

209 Overall mortality, in-hospital mortality, metabolic outcome, graft survival

210 Safety variables (within 30 days) included: in-hospital mortality, myocardial infarction, cerebrovas

211 6 months and were independent predictors of in-hospital mortality, predominantly down-classifying ri

212 imilar, while those for major complications, in-hospital mortality, retrograde type A dissection and

213 pSOFA score had excellent discrimination for in-hospital mortality, with an area under the curve of 0

214 an both SIRS and severe sepsis in predicting in-hospital mortality, with an area under the receiver o

215 The outcome of interest was in-hospital mortality.

216 orbidities, procedure use, and risk-adjusted in-hospital mortality.

217 g labor, maternal readmission at 1 year, and in-hospital mortality.

218 ospitals during times of shortage had higher in-hospital mortality.

219 ds, were associated with lower risk-adjusted in-hospital mortality.

220 6 indicating moderate or severe stroke), and in-hospital mortality.

221 In-hospital mortality.

222 The main outcome was in-hospital mortality.

223 rate hyperchloremia independently predicting in-hospital mortality.

224 usted duration of mechanical ventilation and in-hospital mortality.

225 r mean IV fluids volume, and suffered higher in-hospital mortality.

226 levation myocardial infarction as well as in in-hospital mortality.

227 ion beyond 2003 did not impact risk-adjusted in-hospital mortality.

228 ischarge home but also an unexpectedly lower in-hospital mortality.

229 during a norepinephrine shortage quarter and in-hospital mortality.

230 The main outcome measure was in-hospital mortality.

231 hospital admissions and a 43.5% decrease in in-hospital mortality.

232 ss of each score and the primary outcome was in-hospital mortality.

233 Primary end point was in-hospital mortality; secondary end points included new

234 Of the 3 patient outcomes, only in-hospital myocardial infarction declined significantly

235 bservation, and patient outcomes (mortality, in-hospital myocardial infarction, and not surviving a c

236 h, 4.4%-2.3%; P=0.001) that was not apparent in hospitals not participating in the project during the

237 nt times and mortality with patients treated in hospitals not participating in the project during the

238 Fatigue in hospital nurses is associated with decreased nurse sa

239 and 10 341 (74.8%) of 13 818 deaths occurred in hospital, of which 10 045 (97.1%) followed an emergen

240 l infarction occurred in people who had been in hospital on or within the 28 days preceding death, an

241 iviral therapy combined with a short course (in hospital only) HBIG in liver transplant recipients wi

242 We examined whether disparities existed in hospital-onset (HO) Staphylococcus aureus bloodstream

243 Truong et al. report significant reductions in hospital-onset CDI and oral vancomycin utilization at

244 ), but no significant differences were found in hospital or patient characteristics among high, inter

245 fficile infection per 1000 occupied bed-days in hospitals or per 100 000 inhabitant-days in the commu

246 Primary end point was short-term (in-hospital or 30 days) mortality.

247 data of 2233 subjects who experienced either in-hospital or out-of-hospital cardiac arrest between Ja

248 gement programs and achieving safety culture in hospital organizations.

249 In-hospital outcomes (mortality, length of stay, and dis

250 evaluate contemporary utilization trends and in-hospital outcomes for isolated TV surgery in the Unit

251 ht to evaluate the procedural management and in-hospital outcomes of patients treated for acute myoca

252 We aimed to compare in-hospital outcomes of patients with CKD or ESRD with t

253 Procedural management and in-hospital outcomes were compared among patients treate

254 In-hospital outcomes were recorded, and logistic regress

255 Procedural success, in-hospital outcomes, and midterm mortality were assesse

256 ed association between annual PCI volume and in-hospital outcomes, including mortality.

257 ithrombotic therapy with stroke severity and in-hospital outcomes.

258 However, correlation coefficients in hospitals' paired monthly changes in 30-day RARRs and

259 lcohol problems are not consistently managed in hospital patients.

260 The risk of inpatient mortality is lower in hospitals performing >/=20 TIPS per year.

261 agement) was associated with a lower risk of in-hospital perinatal death (0.08% versus 0.26%; adjuste

262 In-hospital postoperative morbidity and mortality rates

263 uartile range, 9.6-12.3), 82 (9%) died (0.4% in-hospital postoperative mortality).

264 to describe national trends and outcomes of in-hospital postoperative opioid overdose (OD) and ident

265 uate the association between ERR for MI with in-hospital process of care measures and 1-year clinical

266 The median durations of hospitalization and in-hospital prophylaxis were 3 days and 70 hours, respec

267 t pathogens that are notoriously problematic in hospitals: Pseudomonas aeruginosa, Acinetobacter baum

268 s accounted for, suggesting that differences in hospital quality may only partially account for readm

269 To compare in-hospital reperfusion rates and outcomes of ST-segment

270 Associations between baseline and in-hospital risk factors were analyzed for likelihood of

271 easing site volume was associated with lower in-hospital risk-adjusted outcomes, including mortality

272 In-hospital risk-standardized mortality rate (RSMR) calc

273 At the hospital level, mean in-hospital RSMRs and 30-day RSMRs were 6.0% and 14.6%,

274 about hospital safety and should be included in hospital safety surveillance in order to facilitate b

275 ad trauma had differences in prehospital and in-hospital secondary injuries which could have therapeu

276 In-hospital sepsis mortality rates adjusted for patient

277 o estimate 2004-2013 trends in risk-adjusted in-hospital sepsis mortality rates by race/ethnicity to

278 ibe the transmission characteristics of MRSA in hospital setting.

279 pport older patients (>65years) at mealtimes in hospital settings and rehabilitation units.

280 and proliferation of vascular access nursing in hospital settings has been identified as a potential

281 ty of care delivered to people with dementia in hospital settings is of international concern.

282 this noxious gas presents a major challenge in hospital settings.

283 ere was a nonsignificant trend toward higher in-hospital stroke (OR, 1.64; 95% CI, 0.98-2.72; P=0.06)

284 Prior studies have reported higher in-hospital survival with prompt defibrillation and epin

285 tients, they do not determine late mortality in hospital survivors.

286 Race and sex disparities in in-hospital treatment and outcomes of patients with acut

287 nal study of 120 children who were receiving in-hospital treatment of severe acute malnutrition in Ug

288 Children who receive in-hospital treatment of severe acute malnutrition often

289 raphics, clinical history, presentation, and in-hospital treatments were compared by sex and CAD stat

290 ibed meal time assistance for adult patients in hospital units or rehabilitation settings.

291 R) has been proposed as an underlying factor in hospital variation in surgical mortality.

292 The in-hospital vascular complication rate was 1.0%, and thi

293 The length of stay in hospital was similar for both groups (median 4 days [

294 androgens, progestins, and glucocorticoids, in hospital wastewaters, river water, and municipal wast

295 . (2017) show that traits promoting survival in hospitals were acquired upon adaptation to terrestria

296 he greatest odds of increasing ICU beds were in hospitals with 500 or more beds in the highest quarti

297 rgeting stewardship efforts, and feasibility in hospitals with electronic health records.

298 Elective admissions were more common in hospitals with higher annual TIPS volume (20.3% for v

299 In hospitals with low baseline SBT completion, physician

300 highest burden of death and medical expenses in hospitals worldwide.